Company intelligence / Profile preview

Romvac

Voluntari, Ilfov, Romaniaromvac.ro ↗

Ownership: Private
Employees: ~36
Development stage: Commercial

Overview

Romvac has over four decades of experience as Romania’s leading manufacturer of veterinary pharmaceuticals. The company offers more than 260 products including vaccines against major avian diseases such as Marek disease. Its portfolio covers biologicals, small molecules for various indications in animals, diagnostic kits and other veterinary health solutions. It holds a dominant position on the Romanian market for biological and veterinary products. No human clinical results are reported.

Therapeutic areas: OtherInfectious Diseases
Modalities: VaccineBiologicSmall moleculeDiagnostic kitProteinOintment
Industry: Veterinary

Beyond the preview

Go deeper on Romvac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Romvac.